Skip to main content

Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease

  • Protocol

Part of the Methods in Molecular Medicine™ book series (MIMM,volume 66)

Abstract

Alternative strategies exist for prevention of group B Neisseria meningitidis (meningococcal) disease through vaccination (see Chapters 5, 8, 13, 14 in this volume). However, the most promising approach to date has been the use of outer-membrane vesicle (OMV) vaccines for induction of bactericidal antibodies against cell-surface outer-membrane proteins (OMPs).

Keywords

  • Outer Membrane
  • Aluminium Hydroxide
  • Ethylene Diamine Tetraacetic Acid
  • Ethylene Diamine Tetraacetic Acid
  • Meningococcal Disease

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Protocol
USD   49.95
Price excludes VAT (USA)
  • DOI: 10.1385/1-59259-148-5:81
  • Chapter length: 27 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   109.00
Price excludes VAT (USA)
  • ISBN: 978-1-59259-148-0
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Softcover Book
USD   149.99
Price excludes VAT (USA)
Hardcover Book
USD   229.00
Price excludes VAT (USA)
Fig. 1.
Fig. 2.

Springer Nature is developing a new tool to find and evaluate Protocols. Learn more

References

  1. Zollinger, W. D. (1997) New and improved vaccines against meningococcal disease, in New Generation Vaccines, 2nd ed. (Levine, M. M., Woodrow, G. C., Kaper, J. B., and Cobon, G. S., eds.), Marcel Dekker, New York, 469–488.

    Google Scholar 

  2. Bjune, G., Hoiby, E. A., Gronnesby, J. K., Arnesen, O., Fredriksen, J. H., Halstensen, A., et al. (1991) Effect of outer membrane vesicle vaccine against group B meningococcal disease in Norway. Lancet 338, 1093–1096.

    CAS  CrossRef  PubMed  Google Scholar 

  3. Sierra, G. V. G., Campa, H. C., Varcacel, N. M., Izquierdo, P. L., Sotolongo, P. F., Casanueva, G. V., et al. (1991) Vaccine against group B Neisseria meningitidis: Protection trial andmass vaccination results in Cuba. NIPH. Ann. 14, 195–210.

    CAS  PubMed  Google Scholar 

  4. Perkins, B. A., Jonsdottir, K., Briem, H., Griffiths, E., Plikaytis, B. D., Høiby, E. A., et al. (1998) Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland. J. Infect. Dis. 177, 683-669.

    Google Scholar 

  5. Tappero, J. W., Lagos, R., Ballesteros, A. M., Plikaytis B., Williams D., Dykes J., et al. (1999) Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines. A randomized controlled trial in Chile. JAMA 281, 1520–1527.

    CAS  CrossRef  PubMed  Google Scholar 

  6. Milagres, L. G., Ramos, S. R., Sacchi, C. T., Melles, C. E. A., Vieira, V. S. D., Sato, H., et al. (1994) Immune response of Brazilian children to a Neisseria meningitidis serogroup B outer membrane protein vaccine: Comparison with efficacy. Infect. Immun. 62, 4419–4424.

    CAS  PubMed  Google Scholar 

  7. Frasch, C. E. (1995) Meningococcal vaccines: past present and future, in Meningococcal Disease (Cartwright, K. A. V., ed.), John Wiley and Sons, New York, pp. 245–283.

    Google Scholar 

  8. Peltola, H. (1998) Meningococcal vaccines: current status and future possibilities. Drugs 55, 347–366.

    CAS  CrossRef  PubMed  Google Scholar 

  9. Van der Voort, E. M. R., Kuipers, B., Brugghe, H. F., Van Unen, L. M. A., Timmermans, H. A. M., Hoogerhout, P., and Poolman, J. T. (1997) Epitope specificity of murine and human bactericidal antibodies against PorA P1.7,16 induced with experimental meningococcal group B vaccines. FEMS Immunol. Med. Microbiol. 17, 139–148.

    CrossRef  Google Scholar 

  10. Wang, J. F., Jarvis, G. A., Achtman, M., Rosenqvist, E., Michaelsen, T. E., Aase, A., and Griffiss, J. M. (2000) Functional activities and immunoglobulin variable regions of human and murine monoclonal antibodies specific for the P1.7 PorA protein loop of Neisseria meningitides. Infect. Immun. 68, 1871–1878.

    CAS  CrossRef  PubMed  Google Scholar 

  11. Barlow, A. K., Heckels, J. E., and Clarke, I. N. (1989) The class I outer membrane protein of Neisseria meningitidis: Gene sequence, structural and immunological similarities to gonococcal porins. Mol. Microbiol. 3, 131–139.

    CAS  CrossRef  PubMed  Google Scholar 

  12. Minetti, C., Song, J., and Blake, M.S. (1998) Meningococcal PorA class 1 proteins exist in nature as a heterotrimeric proin with porB proteins, in Eleventh International Pathogenic Neisseria Conference (Nassif, X., Quentin-Millet, M-J., and Taha, M-K., eds.), EDK, Paris, p. 15.

    Google Scholar 

  13. Jones, D. M., Borrow, R., Fox, A. J., Gray, S., Cartwright, K. A., and Poolman, J. T. (1992) The lipooligosaccharide immunotype as a virulence determinant in Neisseria meningitidis. Microb. Pathog. 13, 219–224.

    CAS  CrossRef  PubMed  Google Scholar 

  14. Zollinger, W. D., Moran, E. E., Devi, S. J. N., and Frasch, C. E. (1997) Bactericidal antibody responses of juvenile rhesus monkeys immunized with group B Neisseria meningitidis capsular polysaccharide-protein conjugate vaccines. Infect. Immun. 65, 1053–1060.

    CAS  PubMed  Google Scholar 

  15. Sacchi, C. T. (1998) Proposed standardization of Neisseria meningitidis PorA variable-region typing nomenclature. Clin. Diagn. Lab. Immunol. 5, 845–855.

    CAS  PubMed  Google Scholar 

  16. Wetzler, L. M., Blake, M. S., Barry, K., and Gotschlich, E. C. (1992) Gonococcal porin vaccine evaluation: comparison of Por proteosomes, liposomes, and blebs isolated from rmp deletion mutants. J. Infect. Dis. 166, 551–555.

    CAS  PubMed  Google Scholar 

  17. Steeghs, L., Kuipers, B., Hamstra, H. J., Kersten, G., Van Alphen, L., and Van der Ley, P. (1999) Immunogenicity of outer membrane proteins in a lipopolysaccharide-deficient mutant of Neisseria meningitidis: influence of adjuvants on the immune response. Infect. Immun. 67, 4988–4993.

    CAS  PubMed  Google Scholar 

  18. Helting, T. B., Guthohrlein, G., Blackkolb, F., and Ronneberger, H. (1981) Serotype determinant protein of Neisseria Meningitidis. Large scale preparation by direct detergent treatment of the bacterial cells. Acta Pathol. Microbiol. Scand. [C] 89, 69–78.

    CAS  Google Scholar 

  19. Frasch, C. E. (1990) Production and control of Neisseria meningitidis vaccines, in Bacterial Vaccines (Mizrahi, A., ed.), Wiley-Liss, New York, pp. 123–145.

    Google Scholar 

  20. Poolman, J. T. (1990) Polysaccharides and membrane vaccines, in Bacterial Vaccines (Mizrahi, A., ed.), Wiley-Liss, New York, pp. 58–86.

    Google Scholar 

  21. Holst Fredriksen, J., Rosenqvist, E., Wedege, E., Bryn, K., Bjune, G., Frøholm, L. O., et al. (1991). Production characterization and control of MenB-vaccine “Folkehelsa”: an outer membrane vesicle vaccine against group B meningococcal disease. NIPH Ann. 14, 67–80.

    Google Scholar 

  22. Fu, J., Bailey, F. J., King, J. J., Parker, C. B., Robinett, R. S. R., Kolodin, D. G., et al. (1995) Recent advances in the large scale fermentation of Neisseria meningitidis group B for the production of an outer membrane protein complex. BioTechnology 13, 170–174.

    CAS  CrossRef  PubMed  Google Scholar 

  23. Brandileone, M. C., Zanella, R. C., Vieira, V. S., Sacchi, C. T., Milagres, L. C., and Frasch, C. E. (1994) Induction of iron regulated proteins during normal growth of Neisseria meningitidis in a chemically defined medium. Rev. Inst. Med. Trop. Sao Paulo 36, 301–310.

    CAS  PubMed  Google Scholar 

  24. Tsai, C. M., Frasch, C. E., Rivera, E., and Hochstein, H. D. (1989) Measurement of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage. J. Biol. Stand. 17, 249–258.

    CAS  CrossRef  PubMed  Google Scholar 

  25. Rosenqvist, E., Hoiby, E. A., Bjune, G., Aase, A., Halstensen, A., Lehmann, A. K., et al. (1998) Effect of aluminium hydroxide and meningococcal serogroup C capsular polysaccharide on the immunogenicity and reactogenicity of a group B Neisseria meningitidis outer membrane vesicle vaccine. Dev. Biol. Stand. 92, 323–333.

    CAS  PubMed  Google Scholar 

  26. Frasch, C. E., Peppler, M. S., Cate, T. R., and Zahradnik, J. M. (1982) Immunogenicity and clinical evaluation of group B Neisseria meningitidis outer membrane protein vaccines. IN: Robbins, J. B., Hill, J. C., and Sadoff, J. C. (eds.), Sem. Infect. Dis. 4, 263–267, Thieme-Stratton, NY, NY.

    Google Scholar 

  27. Frantz, I. D. (1942) Growth requirements of the meningococcus. J. Bacteriol. 43, 757–761.

    CAS  PubMed  Google Scholar 

  28. Frasch, C. E., McNelis, R. M., and Gotschlich, E. C. (1976) Strain-specific variation in the protein and lipopolysaccharide composition of the group B meningococcal outer membrane. J. Bacteriol. 127, 973–981.

    CAS  PubMed  Google Scholar 

  29. Van der Ley, P. A. and Poolman, J. (1992) Construction of a multivalent meningococcal vaccine strain based on the class 1 outer membrane protein. Infect. Immun. 60, 3156–3161.

    Google Scholar 

  30. Van der Ley, P. A., van der Biezen, J., and Poolman, J. T. (1995) Construction of Neisseria meningitidis strains carrying multiple chromosomal copies of the porA gene for use in the production of a multivalent outer membrane protein vaccine. Vaccine 13, 401–407.

    CAS  CrossRef  PubMed  Google Scholar 

  31. Tommassen, J., Vermeij, P., Struyvé, M., Benz, R., and Poolman, J. T. (1990) Isolation of Neisseria meningitidis mutants deficient in class I (Pora) and class 3 (PorB) outer membrane proteins. Infect. Immun. 58, 1355–1359.

    CAS  PubMed  Google Scholar 

  32. Frosch, M., Schultz, E., Glenn-Clavo, E., and Meyer, T. F. (1990) Generation of capsule-deficient Neisseria meningitidis strains by homologous recombination. Mol. Microbiol. 4, 1215–1218.

    CAS  CrossRef  PubMed  Google Scholar 

  33. Rosenqvist, E., Hoiby, E. A., Wedege, E., Kusecek, B., and Achtman, M. (1993) The 5C protein of Neisseria meningitidis is highly immunogenic in humans and induces bactericidal antibodies. J. Infect. Dis. 167, 1065–1073.

    CAS  PubMed  Google Scholar 

  34. Banerjee-Bhatnager, N. and Frasch, C. E. (1990). Expression of ironregulated outer membrane proteins in Neissera meningitidis including a 70-kDa transferrin receptor and the vaccine potential of these proteins. Infect. Immun. 58, 2875–2881.

    Google Scholar 

  35. Frasch, C. E., Zahradnik, J. M., Wang, L. Y., Mocca, L. F., and Tsai, C. M. (1988) Antibody response of adults to an aluminum hydroxide-adsorbed Neisseria meningitidis serotype 2b protein-group B polysaccharide vaccine. J. Infect. Dis. 158, 710–718.

    CAS  PubMed  Google Scholar 

  36. Hem, S. L. and White, J. L. (1984) Characterization of aluminum hydroxide for use as an adjuvant in parenteral vaccines. J. Parenter. Sci. Technol. 38, 2–10.

    CAS  PubMed  Google Scholar 

  37. Burrell, L. S., Lindblad, E. B., White, J. L., and Hem, S. L. (1999) Stability of aluminium-containing adjuvants to autoclaving. Vaccine 17, 2599–2603.

    CAS  CrossRef  PubMed  Google Scholar 

  38. MacDonald, N. E., Halperin, S. A., Law, B. J., Forrest, B., Danzig, L. E., and Granoff, D. M. (1998) Induction of immunologic memory by conjugated versus plain meningococcal C polysaccharide vaccine in toddlers: a randomized controlled trial. JAMA 280, 1685–1689.

    CAS  CrossRef  PubMed  Google Scholar 

  39. Lieberman, J. M., Chiu, S. S., Wong, V. K., Partridge, S., Chang, S. J., Chiu, C. Y., et al. (1996) Safety and immunogenicity of a serogroups A/C Neisseria meningitides oligosaccharide-protein conjugate vaccine in young children: a randomized controlled trial. J. Amer. Med. Assoc. 275, 1499–1503.

    CAS  CrossRef  Google Scholar 

  40. Fukasawa, L. O., Gorla, M. C. O., Schenkman, R. P. F., Garcia, L. R., Carneiro, S. M., Rawa, I., and Tanizaki, M. M. (1999) Neisseria meningitidis serogroup C polysaccharide and serogroup B outer membrane vesicle conjugate as a bivalent meningococcus vaccine candidate. Vaccine 17, 2951–2958.

    CAS  CrossRef  PubMed  Google Scholar 

  41. Holst Fredriksen, J., Griffiths, E., Grotterød, E. M., Høiby, E. A., Rosenqvist, E., Stevenson, P., and Wedege, E. (1994) Characterization of high molecular weight components in MenB-vaccine “Folkehelsa”; An outer membrane vesicle vaccine against group B meningococcal disease, in Pathobiology and Immunobiology of Neisseriaceae (Conde-Glez, C. J., Morse, S., Rice, P., Sparling, F., and Calderôn, E. eds.), Instituto National de Salud Publica, Cuernovaso, Mexico, pp. 818–824.

    Google Scholar 

  42. Griffiths, E., Sierra, G., and Holst, J. (1994) Quality control of the Cuban and Norwegian serogroup B vaccines used in the Iceland study, in Proceedings of the Ninth International Pathogenic Neisseria Conference (Evans, J. S., Yost, S. E., Maiden, M. C. J., and Feavers, I. M., eds.), Winchester, UK, p. 437.

    Google Scholar 

  43. Claassen, I., Meylis, J., van der Ley, P., Peeters, C., Brons, H., Robert, J., et al. (1996) Production, characterization and control of a Neisseria meningitidis hexavalent class 1 outer membrane protein containing vesicle vaccine. Vaccine 14, 1001–1008.

    CAS  CrossRef  PubMed  Google Scholar 

  44. Wenger, J. D. (1999) Serogroup B meningococcal disease. New outbreaks, new strategies. JAMA 281, 1541–1543.

    CAS  CrossRef  PubMed  Google Scholar 

  45. Peterson, G. L. (1977) A simplification of the protein assay of Lowry et al. which is more generally applicable. Anal. Biochem. 83, 346–356.

    CAS  CrossRef  PubMed  Google Scholar 

  46. Lee, C-H. and Tsai, C-M. (1999) Quantification of bacterial lipopolysaccharide by the Purpald assay: measuring formaldehyde generated from 2-keto-3-deoxyoctonate and heptose at the inner core by periodate oxidation. Anal. Biochem. 267, 161–168.

    CAS  CrossRef  PubMed  Google Scholar 

  47. Tsai, C-M., Frasch, C. E., Rivera, E., and Hochstein, H. D. (1989) Measurement of lipopolysaccharide (endotoxin) in meningococcal protein and polysaccharide preparations for vaccine usage. J. Biol. Stand. 17, 229–258.

    CrossRef  Google Scholar 

  48. Brunborg, G., Holme, J. A., Søderlund, E. G., Omichinski, J. G., and Dybing, E. (1988) An automated alkaline elution system: DNA damage induced by 1,2-dibromo-3-chloropropane in vivo and in vitro. Anal. Biochem. 174, 522–536.

    CAS  CrossRef  PubMed  Google Scholar 

  49. Clarke, A. J., Sarabia, V., Keenleyside, W., MacLachlan, P. R., and Whitfield, C. (1991) The compositional analysis of bacterial extracellular polysaccharides by high-performance anion-exchange chromatography. Anal. Biochem. 199, 68–74.

    CAS  CrossRef  PubMed  Google Scholar 

  50. Abdillahi, A. and Poolman, J. T. (1988) Neisseria meningitidis group B serosubtyping using monoclonal antibodies in whole cell ELISA. Microbiol. Pathog. 4, 27–32.

    CAS  CrossRef  Google Scholar 

  51. Shrivastaw, K. P. and Singh, S. (1995) A new method for spectrophotometric determination of thiomersal in biologicals. Biologicals 23, 65–69.

    CAS  CrossRef  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2001 Humana Press Inc., Totowa, NJ

About this protocol

Cite this protocol

Frasch, C.E., van Alphen, L., Holst, J., Poolman, J.T., Rosenqvist, E. (2001). Outer Membrane Protein Vesicle Vaccines for Meningococcal Disease. In: Pollard, A.J., Maiden, M.C. (eds) Meningococcal Vaccines. Methods in Molecular Medicine™, vol 66. Humana Press. https://doi.org/10.1385/1-59259-148-5:81

Download citation

  • DOI: https://doi.org/10.1385/1-59259-148-5:81

  • Publisher Name: Humana Press

  • Print ISBN: 978-0-89603-801-1

  • Online ISBN: 978-1-59259-148-0

  • eBook Packages: Springer Protocols